BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 8139285)

  • 21. [Acute myelomegakaryocytic leukemia developed from myelodysplastic syndrome after chemotherapy against complicated small cell lung cancer].
    Kume K; Nakamura N; Mori M; Nakazawa S; Enomoto Y; Namiki M
    Rinsho Ketsueki; 1991 Mar; 32(3):261-5. PubMed ID: 1645808
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical Characteristics and Prognosis of 27 Patients with Childhood Acute Megakaryoblastic Leukemia.
    Qi H; Mao Y; Cao Q; Sun X; Kuai W; Song J; Ma L; Hong Z; Hu J; Zhou G
    Med Sci Monit; 2020 Jun; 26():e922662. PubMed ID: 32532951
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The treatment of children with acute megakaryoblastic leukemia who have Down syndrome.
    Zipusky A
    J Pediatr Hematol Oncol; 1996 Feb; 18(1):10-2. PubMed ID: 8556363
    [No Abstract]   [Full Text] [Related]  

  • 24. Erythroblastic and/or megakaryoblastic leukemia in Down syndrome: treatment with low-dose arabinosyl cytosine.
    Tchernia G; Lejeune F; Boccara JF; Denavit MF; Dommergues JP; Bernaudin F
    J Pediatr Hematol Oncol; 1996 Feb; 18(1):59-62. PubMed ID: 8556372
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Acute megakaryoblastic leukemia in children and adolescents: a retrospective analysis of 24 cases.
    Ribeiro RC; Oliveira MS; Fairclough D; Hurwitz C; Mirro J; Behm FG; Head D; Silva ML; Raimondi SC; Crist WM
    Leuk Lymphoma; 1993 Jul; 10(4-5):299-306. PubMed ID: 8220128
    [TBL] [Abstract][Full Text] [Related]  

  • 26. High leukaemia cure rate in Down's syndrome explained.
    Bradbury J
    Lancet Oncol; 2005 Mar; 6(3):134. PubMed ID: 15759357
    [No Abstract]   [Full Text] [Related]  

  • 27. A case of pentasomy 21 with two isochromosome 21s in acute megakaryoblastic leukemia associated with Down syndrome.
    Park Y; Lim J; Ko YH; Kim J; Kwon GC; Koo SH
    Ann Lab Med; 2015 May; 35(3):373-5. PubMed ID: 25932450
    [No Abstract]   [Full Text] [Related]  

  • 28. Ultrastructural and ultracytochemical differences between transient myeloproliferative disorder and megakaryoblastic leukaemia in Down's syndrome.
    Eguchi M; Sakaibara H; Suda J; Ozawa T; Hayashi Y; Sato T; Kojima S; Furukawa T
    Br J Haematol; 1989 Nov; 73(3):315-22. PubMed ID: 2532535
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Megakaryocytic leukemia cell lines and megakaryocytic leukemia].
    Ryo R; Yoshida A; Yamaguchi N
    Rinsho Byori; 1990 May; 38(5):514-23. PubMed ID: 2381077
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A case of acute megakaryocytic leukemia with hematogones.
    Richard G; Brody J; Sun T
    Leukemia; 1993 Nov; 7(11):1900-3. PubMed ID: 8231260
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Myelodysplasia predominantly involving in megakaryocytic lineage successfully treated with low-dose Ara-C].
    Tsushita K; Hotta T; Inoue C; Ichikawa A; Murate T; Saito H
    Rinsho Ketsueki; 1991 Aug; 32(8):897-902. PubMed ID: 1942532
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Acute megakaryoblastic leukemia in Down syndrome: orbital infiltration.
    Olson JL; May MJ; Stork L; Kadan N; Bateman JB
    Am J Ophthalmol; 2000 Jul; 130(1):128-30. PubMed ID: 11004278
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Acute megakaryoblastic leukemia in children and adolescents, excluding Down's syndrome: improved outcome with intensified induction treatment.
    Reinhardt D; Diekamp S; Langebrake C; Ritter J; Stary J; Dworzak M; Schrauder A; Zimmermann M; Fleischhack G; Ludwig WD; Harbott J; Creutzig U
    Leukemia; 2005 Aug; 19(8):1495-6. PubMed ID: 15920489
    [No Abstract]   [Full Text] [Related]  

  • 34. Down's syndrome and acute megakaryoblastic leukaemia. Case report and review of the literature.
    Lewis DS; Thompson M; Hudson E; Liberman MM; Samson D
    Acta Haematol; 1983; 70(4):236-42. PubMed ID: 6226169
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Recovery of polyclonal hematopoiesis in patients with myelodysplastic syndromes following successful chemotherapy.
    Ito T; Ohashi H; Kagami Y; Ichikawa A; Saito H; Hotta T
    Leukemia; 1994 May; 8(5):839-43. PubMed ID: 7910221
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Megakaryoblastic leukemia and Down's syndrome--a review.
    Zipursky A; Peeters M; Poon A
    Prog Clin Biol Res; 1987; 246():33-56. PubMed ID: 2958881
    [No Abstract]   [Full Text] [Related]  

  • 37. Establishment of a human leukaemic cell line (CMK) with megakaryocytic characteristics from a Down's syndrome patient with acute megakaryoblastic leukaemia.
    Sato T; Fuse A; Eguchi M; Hayashi Y; Ryo R; Adachi M; Kishimoto Y; Teramura M; Mizoguchi H; Shima Y
    Br J Haematol; 1989 Jun; 72(2):184-90. PubMed ID: 2527057
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Acute megakaryoblastic leukemia and clonal trisomy 21 in a phenotypically normal infant.
    Arico M
    Blood; 1991 Jun; 77(11):2542-3. PubMed ID: 1828181
    [No Abstract]   [Full Text] [Related]  

  • 39. Acute megakaryoblastic leukemia.
    Gassmann W; Löffler H
    Leuk Lymphoma; 1995; 18 Suppl 1():69-73. PubMed ID: 7496359
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Relationship between transient abnormal myelopoiesis and acute megakaryoblastic leukaemia in Down's syndrome.
    Ma SK; Wan TS; Chan GC; Ha SY; Fung LF; Chan LC
    Br J Haematol; 2001 Mar; 112(3):824-5. PubMed ID: 11260090
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.